These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Clinical features and prognosis of bronchopulmonary dysplasia complicated by pulmonary hypertension in preterm infants]. Wang CH; Shi LP; Ma XL; DU LZ Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):893-896. PubMed ID: 30477618 [TBL] [Abstract][Full Text] [Related]
10. Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System. Chao CM; Chong L; Chu X; Shrestha A; Behnke J; Ehrhardt H; Zhang J; Chen C; Bellusci S Cells; 2020 Aug; 9(8):. PubMed ID: 32796770 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants]. Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715 [No Abstract] [Full Text] [Related]
12. Pulmonary Hypertension Associated with Bronchopulmonary Dysplasia: A Review. Varghese N; Rios D Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):140-148. PubMed ID: 31871821 [TBL] [Abstract][Full Text] [Related]
13. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension is an important co-morbidity in developmental lung diseases of infancy: Bronchopulmonary dysplasia and congenital diaphragmatic hernia. Varghese NP; Tillman RH; Keller RL Pediatr Pulmonol; 2021 Mar; 56(3):670-677. PubMed ID: 33561308 [TBL] [Abstract][Full Text] [Related]
15. Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant. Rivera L; Siddaiah R; Oji-Mmuo C; Silveyra GR; Silveyra P Front Pediatr; 2016; 4():33. PubMed ID: 27065351 [TBL] [Abstract][Full Text] [Related]
16. Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia. El-Saie A; Shivanna B Front Pediatr; 2020; 8():201. PubMed ID: 32457857 [TBL] [Abstract][Full Text] [Related]
17. Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia. Varghese NP; Altit G; Gubichuk MM; Siddaiah R J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38929946 [TBL] [Abstract][Full Text] [Related]
18. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age. Choi EK; Shin SH; Kim EK; Kim HS BMC Pediatr; 2019 Jan; 19(1):26. PubMed ID: 30654786 [TBL] [Abstract][Full Text] [Related]
19. Soluble Klotho, a biomarker and therapeutic strategy to reduce bronchopulmonary dysplasia and pulmonary hypertension in preterm infants. Batlahally S; Franklin A; Damianos A; Huang J; Chen P; Sharma M; Duara J; Keerthy D; Zambrano R; Shehadeh LA; Martinez EC; DeFreitas MJ; Kulandavelu S; Abitbol CL; Freundlich M; Kanashiro-Takeuchi RM; Schmidt A; Benny M; Wu S; Mestan KK; Young KC Sci Rep; 2020 Jul; 10(1):12368. PubMed ID: 32704023 [TBL] [Abstract][Full Text] [Related]
20. Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants. Arjaans S; Wagner BD; Mourani PM; Mandell EW; Poindexter BB; Berger RMF; Abman SH Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L644-L654. PubMed ID: 31967847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]